Clinical Trial Update: Study Of Sunitinib With Capecitabine In Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of sunitinib with capecitabine in patients with advanced or metastatic breast cancer; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sutent (sunitinib)
• Xeloda (capecitabine)

Snippet

Sponsor: Pfizer | Conditions: Advanced/Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-10-13